Absci Corp (ABSI)

$2.82 +0.18 (6.82%)
Market Cap 394.74M
Revenue (ttm) 4.53M
Net Income (ttm) -103.11M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -2,276.16%
Debt to Equity Ratio 0.01
Volume 7,295,400
Avg Vol 5,825,980
Day's Range N/A - N/A
Shares Out 149.52M
Stochastic %K 15%
Beta 2.11
Analysts Strong Sell
Price Target $7.98

Company Profile

Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to design differentiated antibody therapeutics. Its preclinical development programs include ABS-101 for the treatment of inflammatory bowel disease; ABS-201 for treating androgenic alopecia; ABS-301 for the treatment of immuno-oncology; and ABS-501 for treating oncology. Absci Corporation has collaboration agree...

Industry: Biotechnology
Sector: Healthcare
Phone: 360 949 1041
Address:
18105 SE Mill Plain Boulevard, Vancouver, United States
AlejandroDickerson
AlejandroDickerson Nov. 15 at 3:21 PM
$DFP $ABSI The market is nowshrouded in bullish sentiment.
0 · Reply
KeenInsight
KeenInsight Nov. 14 at 7:08 PM
$ABSI $NVDA $PLTR $TSLA Nvdia's leader Jensen Huang is truly remarkable; Palantir's leader Alex Karp is truly remarkable; obviously, Tesla's leader Elon Musk is truly remarkable. If you're really tuned in to a company and paying attention to all the details, it becomes obvious when a company has a truly great, extremely talented and competent leader (or not). I believe that sometime soon, the public will come to realize that Absci's amazing Founder-CEO Sean McClain is also one of those rare truly remarkable company leaders. His vision for what's possible with Absci is limitless. Just Google the podcast that Sean McClain did with host Ark Invest's Cathie Wood yesterday and watch all 54 minutes of it to get a strong sense of how dialed in Sean's bigger picture vision is. He will lead Absci to great achievements in AI Biotech. Absci's approach to new drug discovery is unlike any other public company's. What they're doing stands apart from the rest of the field and just make sense.
0 · Reply
LabPsycho
LabPsycho Nov. 14 at 6:03 PM
$ABSI @ArsenicSauce Instead of Google citing inflated # from biased science articles, use some heuristic and deductive thinking: 90M out of 360M = 1 in 4 males and females. Most would be males. So that is 1 in 2 males to get to 90M. Almost none below 25 yr old so that eliminates that subpopulation. Now its ~ 3/5 males. Most with hair loss normal. Is that what you would think from observing the population?
1 · Reply
Invest2live
Invest2live Nov. 14 at 5:12 PM
$CYPH 562% in less than a week; congrats 🌿🎉🎈 Who got the cheap shares at .37 when I alerted. 700% already. Follow for more research based stock alerts. Check out $LCTX and $ABSI for long.
1 · Reply
LabPsycho
LabPsycho Nov. 14 at 3:53 PM
$ABSI "Drug Creation Partnerships: Absci continues to make further progress on its existing drug creation partnerships and anticipates signing one or more partnerships, including with a Large Pharma company, in 2025" Novartis maybe? They seem to like companies doing advanced computational chemistry (GLUE recent example with + $ 150 million investment
0 · Reply
LabPsycho
LabPsycho Nov. 14 at 2:58 PM
$ABSI Alex, I'll take category Phantasmagorically Optimistic Stats for $500: "androgenetic alopecia....large potential patient population of approximately 80 million individuals in the U.S. alone" So a quarter of the population? In a country with rapidly declining testosterone? Help me understand how they may have arrived at this number.
1 · Reply
blockzilla
blockzilla Nov. 14 at 2:49 PM
$ABSI loaded, sent it with haste!
0 · Reply
flam70
flam70 Nov. 14 at 1:57 PM
$ABSI arkg bought 400,000 shares yesterday. I guess Cathie is not leaving so quick.
1 · Reply
KeenInsight
KeenInsight Nov. 14 at 9:54 AM
$ABSI $AMD $RXRX $NVDA There's mainly two publicly traded drug discovery companies that have received significant investment from the world's top chip-maker tech companies: Nvidia invested in Recursion, and AMD invested in Absci. This is because those two companies are leading the charge of truly using AI for new drug discovery. Most people haven't heard of Absci, but I feel its breakout is soon arriving, just as AI had its big breakout recently. Sean McClain is the phenomenal Founder-CEO of Absci, and he's so intelligent and hyper-aware of everything that he reminds me of a cross between Jack Dorsey and Elon Musk. Just Google Cathie Wood's Ark invest podcast from yesterday "Curing hair loss with Sean McClain" and listen to all 54 minutes of it to blow your mind to the enormous potential of Absci. They even talk about total target markets worth quadrillions. Sean McClain and his company Absci are absolutely the real deal, which you'll fully agree after hearing that full podcast.
2 · Reply
_SquidGains_
_SquidGains_ Nov. 13 at 10:52 PM
$ABSI $SYM $IBKR $PEP w
0 · Reply
Latest News on ABSI
Absci Corporation (ABSI) Q3 2025 Earnings Call Transcript

Nov 12, 2025, 10:31 PM EST - 2 days ago

Absci Corporation (ABSI) Q3 2025 Earnings Call Transcript

Absci Reports Business Updates and Third Quarter 2025 Financial and Operating Results

Nov 12, 2025, 4:05 PM EST - 2 days ago

Absci Reports Business Updates and Third Quarter 2025 Financial and Operating Results

Absci to Report Business Updates and Third Quarter 2025 Financial and Operating Results on November 12, 2025

Oct 29, 2025, 4:05 PM EDT - 16 days ago

Absci to Report Business Updates and Third Quarter 2025 Financial and Operating Results on November 12, 2025

Absci to Participate in Upcoming Investor Conferences

Oct 27, 2025, 8:00 AM EDT - 19 days ago

Absci to Participate in Upcoming Investor Conferences

Absci to Host KOL Seminar on ABS-201 Androgenetic Alopecia Program on December 11, 2025; Announces Accelerated Initiation of Phase 1/2a Trial

Oct 15, 2025, 8:00 AM EDT - 4 weeks ago

Absci to Host KOL Seminar on ABS-201 Androgenetic Alopecia Program on December 11, 2025; Announces Accelerated Initiation of Phase 1/2a Trial

Absci Boosts AI-Powered Drug Discovery With Oracle And AMD Collaboration

Sep 11, 2025, 12:10 PM EDT - 2 months ago

Absci Boosts AI-Powered Drug Discovery With Oracle And AMD Collaboration

AMD ORCL

Absci Accelerates AI-Driven Drug Discovery with Oracle and AMD

Sep 11, 2025, 8:00 AM EDT - 2 months ago

Absci Accelerates AI-Driven Drug Discovery with Oracle and AMD

Absci Corporation (ABSI) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 9, 2025, 12:13 AM EDT - 2 months ago

Absci Corporation (ABSI) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Absci Expands ABS-201 Scientific Advisory Board with Addition of Leading Dermatology Experts Dr. Rodney Sinclair and Dr. David Goldberg

Aug 25, 2025, 4:05 PM EDT - 2 months ago

Absci Expands ABS-201 Scientific Advisory Board with Addition of Leading Dermatology Experts Dr. Rodney Sinclair and Dr. David Goldberg

Absci Corporation (ABSI) Q2 2025 Earnings Call Transcript

Aug 13, 2025, 12:25 AM EDT - 3 months ago

Absci Corporation (ABSI) Q2 2025 Earnings Call Transcript

Absci Reports Business Updates and Second Quarter 2025 Financial and Operating Results

Aug 12, 2025, 4:05 PM EDT - 3 months ago

Absci Reports Business Updates and Second Quarter 2025 Financial and Operating Results

Almirall and Absci Expand AI Drug Creation Collaboration Adding a Second Dermatology Target

Aug 7, 2025, 2:00 AM EDT - 3 months ago

Almirall and Absci Expand AI Drug Creation Collaboration Adding a Second Dermatology Target

Absci to Report Business Updates and Second Quarter 2025 Financial and Operating Results on August 12, 2025

Jul 30, 2025, 4:05 PM EDT - 3 months ago

Absci to Report Business Updates and Second Quarter 2025 Financial and Operating Results on August 12, 2025

Intel, Absci, AST SpaceMobile And Other Big Stocks Moving Lower In Friday's Pre-Market Session

Jul 25, 2025, 8:34 AM EDT - 4 months ago

Intel, Absci, AST SpaceMobile And Other Big Stocks Moving Lower In Friday's Pre-Market Session

ASTS INTC

Absci Announces Pricing of Public Offering of Common Stock

Jul 24, 2025, 8:45 PM EDT - 4 months ago

Absci Announces Pricing of Public Offering of Common Stock

Absci Announces Proposed Public Offering of Common Stock

Jul 24, 2025, 4:54 PM EDT - 4 months ago

Absci Announces Proposed Public Offering of Common Stock

Absci Appoints Biopharma Leader Mary Szela to Board of Directors

Jul 7, 2025, 8:00 AM EDT - 4 months ago

Absci Appoints Biopharma Leader Mary Szela to Board of Directors

Absci Corporation (ABSI) Q1 2025 Earnings Call Transcript

May 13, 2025, 10:45 PM EDT - 6 months ago

Absci Corporation (ABSI) Q1 2025 Earnings Call Transcript

Absci Reports Business Updates and First Quarter 2025 Financial and Operating Results

May 13, 2025, 4:05 PM EDT - 6 months ago

Absci Reports Business Updates and First Quarter 2025 Financial and Operating Results

Absci Announces First Participants Dosed in Phase 1 Clinical Trial of ABS-101, a Potential Best-In-Class anti-TL1A Antibody for the Treatment of Inflammatory Bowel Disease

May 13, 2025, 4:01 PM EDT - 6 months ago

Absci Announces First Participants Dosed in Phase 1 Clinical Trial of ABS-101, a Potential Best-In-Class anti-TL1A Antibody for the Treatment of Inflammatory Bowel Disease

Absci to Report Business Updates and First Quarter 2025 Financial and Operating Results on May 13, 2025

Apr 14, 2025, 4:05 PM EDT - 7 months ago

Absci to Report Business Updates and First Quarter 2025 Financial and Operating Results on May 13, 2025

Absci Corporation: A Potential Turnaround Play In Biotech Amid A Tumultuous Market

Apr 3, 2025, 3:15 PM EDT - 8 months ago

Absci Corporation: A Potential Turnaround Play In Biotech Amid A Tumultuous Market

Absci Posts Downbeat Results, Joins HealthEquity, Tonix Pharmaceuticals And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Mar 19, 2025, 8:15 AM EDT - 8 months ago

Absci Posts Downbeat Results, Joins HealthEquity, Tonix Pharmaceuticals And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

HQY TNXP

Absci Corporation (ABSI) Q4 2024 Earnings Call Transcript

Mar 18, 2025, 7:37 PM EDT - 8 months ago

Absci Corporation (ABSI) Q4 2024 Earnings Call Transcript

Absci Reports Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results

Mar 18, 2025, 4:05 PM EDT - 8 months ago

Absci Reports Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results

Absci to Report Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results on March 18, 2025

Mar 4, 2025, 4:05 PM EST - 9 months ago

Absci to Report Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results on March 18, 2025

Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Mar 4, 2025, 4:00 PM EST - 9 months ago

Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Absci to Participate in the KeyBanc Capital Markets Healthcare Forum

Mar 4, 2025, 8:00 AM EST - 9 months ago

Absci to Participate in the KeyBanc Capital Markets Healthcare Forum

Absci to Participate in the TD Cowen 45th Annual Health Care Conference

Feb 18, 2025, 8:00 AM EST - 9 months ago

Absci to Participate in the TD Cowen 45th Annual Health Care Conference

Analyst Praises AMD-Partner Absci's Practical Approach, Sees 118% Stock Upside

Jan 22, 2025, 1:22 PM EST - 10 months ago

Analyst Praises AMD-Partner Absci's Practical Approach, Sees 118% Stock Upside

AMD

Absci to Participate in the Guggenheim Securities SMID Cap Biotech Conference

Jan 22, 2025, 8:00 AM EST - 10 months ago

Absci to Participate in the Guggenheim Securities SMID Cap Biotech Conference

Absci Looks Cheap And Positioned For Growth With AMD's AI Backing

Jan 13, 2025, 2:05 AM EST - 10 months ago

Absci Looks Cheap And Positioned For Growth With AMD's AI Backing

AMD

Absci and Owkin Synergize Leading TechBio Platforms to Advance Generative AI Drug Discovery

Jan 10, 2025, 7:30 AM EST - 11 months ago

Absci and Owkin Synergize Leading TechBio Platforms to Advance Generative AI Drug Discovery

Absci and AMD Announce Collaboration and Strategic Investment to Accelerate the Future of AI Drug Discovery

Jan 8, 2025, 7:00 AM EST - 11 months ago

Absci and AMD Announce Collaboration and Strategic Investment to Accelerate the Future of AI Drug Discovery

Absci and Invetx Partner to Bring Generative AI Drug Creation Platform to Animal Health

Jan 6, 2025, 8:00 AM EST - 11 months ago

Absci and Invetx Partner to Bring Generative AI Drug Creation Platform to Animal Health

Absci Corporation (ABSI) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 10:01 AM EST - 1 year ago

Absci Corporation (ABSI) Q3 2024 Earnings Call Transcript

Absci Reports Business Updates and Third Quarter 2024 Financial and Operating Results

Nov 12, 2024, 7:30 AM EST - 1 year ago

Absci Reports Business Updates and Third Quarter 2024 Financial and Operating Results

Absci to Host R&D Day on December 12, 2024

Nov 7, 2024, 8:00 AM EST - 1 year ago

Absci to Host R&D Day on December 12, 2024

Absci to Report Business Updates and Third Quarter 2024 Financial and Operating Results on November 12, 2024

Oct 15, 2024, 8:00 AM EDT - 1 year ago

Absci to Report Business Updates and Third Quarter 2024 Financial and Operating Results on November 12, 2024

Absci: AI-Driven Platform Could Establish Best-In-Class TL1A Drug Targeting Profile

Oct 3, 2024, 12:36 PM EDT - 1 year ago

Absci: AI-Driven Platform Could Establish Best-In-Class TL1A Drug Targeting Profile

Absci Corporation (ABSI) Q2 2024 Earnings Call Transcript

Aug 16, 2024, 11:50 PM EDT - 1 year ago

Absci Corporation (ABSI) Q2 2024 Earnings Call Transcript

Absci Reports Business Updates and Second Quarter 2024 Financial and Operating Results

Aug 14, 2024, 4:01 PM EDT - 1 year ago

Absci Reports Business Updates and Second Quarter 2024 Financial and Operating Results

Absci Collaborates with Global Cancer Center to Discover Novel Therapeutics Using Generative AI

Aug 12, 2024, 8:00 AM EDT - 1 year ago

Absci Collaborates with Global Cancer Center to Discover Novel Therapeutics Using Generative AI

Absci Corporation Leverages AI For Rapid Drug Discovery And Promising Partnerships

Jul 28, 2024, 1:24 AM EDT - 1 year ago

Absci Corporation Leverages AI For Rapid Drug Discovery And Promising Partnerships

Absci to Report Business Updates and Second Quarter 2024 Financial and Operating Results on August 14, 2024

Jul 10, 2024, 8:00 AM EDT - 1 year ago

Absci to Report Business Updates and Second Quarter 2024 Financial and Operating Results on August 14, 2024

Absci to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

May 28, 2024, 8:00 AM EDT - 1 year ago

Absci to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

Absci Corporation (ABSI) Q1 2024 Earnings Call Transcript

May 14, 2024, 1:30 PM EDT - 1 year ago

Absci Corporation (ABSI) Q1 2024 Earnings Call Transcript

Absci Reports Business Updates and First Quarter 2024 Financial and Operating Results

May 14, 2024, 7:30 AM EDT - 1 year ago

Absci Reports Business Updates and First Quarter 2024 Financial and Operating Results

Absci Reports Business Updates and Fourth Quarter and Full Year 2023 Financial and Operating Results

Mar 21, 2024, 7:30 AM EDT - 1 year ago

Absci Reports Business Updates and Fourth Quarter and Full Year 2023 Financial and Operating Results

Absci Announces Closing of Public Offering of Common Stock Including Full Exercise of the Underwriters' Option to Purchase Additional Shares

Mar 1, 2024, 4:01 PM EST - 1 year ago

Absci Announces Closing of Public Offering of Common Stock Including Full Exercise of the Underwriters' Option to Purchase Additional Shares

AlejandroDickerson
AlejandroDickerson Nov. 15 at 3:21 PM
$DFP $ABSI The market is nowshrouded in bullish sentiment.
0 · Reply
KeenInsight
KeenInsight Nov. 14 at 7:08 PM
$ABSI $NVDA $PLTR $TSLA Nvdia's leader Jensen Huang is truly remarkable; Palantir's leader Alex Karp is truly remarkable; obviously, Tesla's leader Elon Musk is truly remarkable. If you're really tuned in to a company and paying attention to all the details, it becomes obvious when a company has a truly great, extremely talented and competent leader (or not). I believe that sometime soon, the public will come to realize that Absci's amazing Founder-CEO Sean McClain is also one of those rare truly remarkable company leaders. His vision for what's possible with Absci is limitless. Just Google the podcast that Sean McClain did with host Ark Invest's Cathie Wood yesterday and watch all 54 minutes of it to get a strong sense of how dialed in Sean's bigger picture vision is. He will lead Absci to great achievements in AI Biotech. Absci's approach to new drug discovery is unlike any other public company's. What they're doing stands apart from the rest of the field and just make sense.
0 · Reply
LabPsycho
LabPsycho Nov. 14 at 6:03 PM
$ABSI @ArsenicSauce Instead of Google citing inflated # from biased science articles, use some heuristic and deductive thinking: 90M out of 360M = 1 in 4 males and females. Most would be males. So that is 1 in 2 males to get to 90M. Almost none below 25 yr old so that eliminates that subpopulation. Now its ~ 3/5 males. Most with hair loss normal. Is that what you would think from observing the population?
1 · Reply
Invest2live
Invest2live Nov. 14 at 5:12 PM
$CYPH 562% in less than a week; congrats 🌿🎉🎈 Who got the cheap shares at .37 when I alerted. 700% already. Follow for more research based stock alerts. Check out $LCTX and $ABSI for long.
1 · Reply
LabPsycho
LabPsycho Nov. 14 at 3:53 PM
$ABSI "Drug Creation Partnerships: Absci continues to make further progress on its existing drug creation partnerships and anticipates signing one or more partnerships, including with a Large Pharma company, in 2025" Novartis maybe? They seem to like companies doing advanced computational chemistry (GLUE recent example with + $ 150 million investment
0 · Reply
LabPsycho
LabPsycho Nov. 14 at 2:58 PM
$ABSI Alex, I'll take category Phantasmagorically Optimistic Stats for $500: "androgenetic alopecia....large potential patient population of approximately 80 million individuals in the U.S. alone" So a quarter of the population? In a country with rapidly declining testosterone? Help me understand how they may have arrived at this number.
1 · Reply
blockzilla
blockzilla Nov. 14 at 2:49 PM
$ABSI loaded, sent it with haste!
0 · Reply
flam70
flam70 Nov. 14 at 1:57 PM
$ABSI arkg bought 400,000 shares yesterday. I guess Cathie is not leaving so quick.
1 · Reply
KeenInsight
KeenInsight Nov. 14 at 9:54 AM
$ABSI $AMD $RXRX $NVDA There's mainly two publicly traded drug discovery companies that have received significant investment from the world's top chip-maker tech companies: Nvidia invested in Recursion, and AMD invested in Absci. This is because those two companies are leading the charge of truly using AI for new drug discovery. Most people haven't heard of Absci, but I feel its breakout is soon arriving, just as AI had its big breakout recently. Sean McClain is the phenomenal Founder-CEO of Absci, and he's so intelligent and hyper-aware of everything that he reminds me of a cross between Jack Dorsey and Elon Musk. Just Google Cathie Wood's Ark invest podcast from yesterday "Curing hair loss with Sean McClain" and listen to all 54 minutes of it to blow your mind to the enormous potential of Absci. They even talk about total target markets worth quadrillions. Sean McClain and his company Absci are absolutely the real deal, which you'll fully agree after hearing that full podcast.
2 · Reply
_SquidGains_
_SquidGains_ Nov. 13 at 10:52 PM
$ABSI $SYM $IBKR $PEP w
0 · Reply
_SquidGains_
_SquidGains_ Nov. 13 at 9:07 PM
ARBB next major retail squeeze candidate right here!!!! 500k Nano float 🔥 $DPRO $SLRX $HSAI $ABSI 💡
0 · Reply
musky54
musky54 Nov. 13 at 8:32 PM
$ABSI pass the bucket I’m about to get sick
1 · Reply
Jacob6444
Jacob6444 Nov. 13 at 8:25 PM
$ABSI almost time to buy back in.
0 · Reply
LeronLegend_Visionary
LeronLegend_Visionary Nov. 13 at 8:18 PM
$ABSI 2 times was up a good percentage but I don’t know what the heck was I thinking not to get the heck out. Not happening again.
0 · Reply
sogenerous
sogenerous Nov. 13 at 7:57 PM
$ABSI one of the easier sells last month
0 · Reply
healthcareguru
healthcareguru Nov. 13 at 7:33 PM
$ABSI Once again, WHAT DID I SAY?!?!?!?!? 😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂 #TEAMGURU thanks you for your $$, suckers! 🐺👎
0 · Reply
Momabeat
Momabeat Nov. 13 at 6:53 PM
$ABSI loaded up on the dip
0 · Reply
KeenInsight
KeenInsight Nov. 13 at 6:52 PM
$ABSI $AMD $ORCL Absci has already shown fantastic preliminary results for ABS-201 that would place it as one of the best treatments for pattern baldness. The official trials to confirm their preliminary success with ABS-201 will start next month. If the official trials confirm their successful findings, this stock will explode upwards overnight. That is not even factoring in that their treatment for endometriosis could prove to be a successful leading treatment. And it doesn't include the many other irons in the fire it has, like gaining tons of revenue for assisting other big companies to development new treatments. AMD and ORACLE would not have supported and invested in Absci if they didn't believe in their capabilities
0 · Reply
KeenInsight
KeenInsight Nov. 13 at 6:36 PM
$ABSI Take advantage of this dip because the market is not factoring in the huge development that was just disclosed during earnings that ABS-201 will be going through trials to treat endometriosis, which effects 190 million women globally. This huge news in Absci's earnings report more than offsets the pause in ABS-101 while they search for a partner to help develop that after it showed promising preliminary re sults, because a partner can foot the bill on further testing of ABS-101 while the company makes the smart play of focusing on the two ginormous addressable markets for ABS-201 of treating pattern baldness and treating endometriosis which together affect 1.4 billion people. Plus, Absci continues to have multiple other irons in the fire. This should easily be a $10 stock, not a less than $3 stock. Huge upside! And if testing shows additional success this coming year, then this could be a $100 stock!
0 · Reply
Arcides
Arcides Nov. 13 at 6:25 PM
$ABSI horrible
0 · Reply
flam70
flam70 Nov. 13 at 5:16 PM
$ABSI https://youtu.be/AuXSCYoxIzQ?si=STMlKk-ikaG3HI5L
0 · Reply
UncleTrump
UncleTrump Nov. 13 at 3:28 PM
$ABSI I am in with 5k shares with an average off $2.76. LFG now. Lets make some money here.
2 · Reply